Novostia is a Switzerland-based healthcare startup founded in 2017 with the slogan "Heart valves for life, for patients of any age, including children." The company specializes in the development of an innovative artificial heart valve designed to cater to patients of all age groups, including children. Novostia's primary goal is to advance its technology to the stage of clinical trials and regulatory approvals with the aim of enhancing the quality of life for millions worldwide who are affected by aortic and mitral valve disease. Their latest funding round, a €2.50M Series A investment, took place on 01 May 2023. For more information about Novostia, interested parties can visit www.novostia.com.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series A | €2.50M | - | 01 May 2023 | |
Venture Round | €2.50M | 1 | Horizon 2020 | 14 Jan 2020 |
Seed Round | Fr.6.50M | - | 22 Feb 2019 |
No recent news or press coverage available for Novostia.